{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-014338","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2026-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.546061+00:00","generated_at":"2026-05-16T03:30:54.781189+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma Holdings acquires topiroxostat nanoemulsion patent for $8.82M in stock","bullets":["Transfer price of $8.82M paid in 12.6M restricted shares at $0.70/share; closing by Feb 20, 2026.","Transferor Xiaoyun Chen to provide technical services including R&D and registration.","Transferor also entitled to 3% of net profit from product after commercial launch.","Patent covers Topiroxostat Nanoemulsion and method; patent expires July 2036."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-014338","json":"https://secwatch.observer/filing/0001213900-26-014338.json","markdown":"https://secwatch.observer/filing/0001213900-26-014338.md","text":"https://secwatch.observer/filing/0001213900-26-014338.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/0001213900-26-014338-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/ea0276369-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:30:54.781189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c848f04f8345e89a62e2465ae19068b0d53048e9","claim":"CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Xiaoyun Chen valued at $8.82 million in common stock at $0.70 per share (effective 2026-02-05).","evidence_excerpt":"On February 5, 2026 (the \"Signing Date\"), Hainan Helpson Medical & Biotechnology Co., Ltd (\" Helpson \"), a wholly owned subsidiary of China Pharma Holdings, Inc. (the \" Company \"), entered into a Technology Transfer Agreement (the \" Agreement \") with Xiaoyun Chen (the \" Transferor \").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026014338/0001213900-26-014338-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Xiaoyun Chen"},{"label":"Value","value":"$8.82 million in common stock at $0.70 per share"},{"label":"Effective","value":"2026-02-05"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}